Telstar O40 Logistic Center

The company relocates its logistic center to a new higher-capacity modern installation

Telstar has strengthened the logistics activity with the relocation of its specialized center to a new, larger facility which enables the company to respond to the sustained demand growth, with a 10% rising foreseen for 2020, through an efficient and competitive operational management of logistics activity, in addition of reaching a 30% reduction in delivery time of laboratory equipment.

Located near the headquarters of the firm in Terrassa (Barcelona), Telstar Logistics center covers operational functions involved in the material flow planning and control processes based on three fundamental activities: reception of materials & stock management, picking process and product preparation for production activity and expedition of material for sale & delivering.

With a height of 12.75 meters, the new installation offers 64% higher capacity than the former facility. The modern center occupies a surface area of 1,979 m2 with a storage capacity of 22.542 m3, with space available to accommodate 1,692 bin locations in the new installed shelves. Within a large vertical configuration diaphanous space, the new location suits the specific functional requirements of a high-efficient internal and external logistics assistance.

Telstar is acknowledged as one of the 10 major suppliers to the pharmaceutical industry. The company has a solid commitment with a continuous development of technologies for the life science markets and a robust background endorsed by the development of more than 1,700 installations of integrated process equipment & systems over 50 years. Telstar has a consolidated activity in engineering & construction of complete turnkey pharmaceutical and biotech production facilities, critical installations, clean rooms, and R&D laboratories.

Subscribirse al Directorio
Escribir un Artículo

Últimas Noticias

Tuneable reverse photochromes in the sol...

A new technique allows the design of solid materia...

La Unidad de Chequeos de la Clínica sup...

El estudio realizado sobre una muestra significati...

Destacadas

Entrevista con Dámaso Molero, director ...

by 3P Biopharmaceuticals

Dámaso Molero:" Creo que en Latinoamérica habrá negocio en el d...

Hallan nuevas evidencias de los efectos ...

by Universitat Rovira i Virgili

Investigadoras de la URV participan un estudio pionero que analiza las...

Diapositiva de Fotos